Our Campus Research is Funded by the Following Extramural Sources:


PI Award # Title Project Period Award Amount

Jean-Marc Schwarz
(Joint PI)

Alejandro Gugliucci

NIH, 5R01HL113887 Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency 6/1/2013 - 5/31/2018 $3,065,341
Jean-Marc Schwarz
(PI, Subcontract)
NIH, 1R01HL121324 Adverse metabolic effects of dietary sugar_Ad libitum vs energy-balanced diets 08/27/2014 - 05/31/2019 $1,752,604
Michael Clearfield
(PI, Subcontract)
NIH, U01HL101422 Cardiovascular Inflammation Reduction Trial 02/01/2013 - 04/30/2017  
Alejandro Gugliucci (I) UCSF The Metabolic Syndrome Project 07/01/2015 - 06/30/2017 $37,500
Jay Shubrook
(Co-I, Subcontract, Clinical Trial)
NIH, 5R18DK092765 Program ACTIVE II: Behavioral Depression Treatment for Type 2 Diabetes 08/01/2015 - 07/31/2016 $12,633
Jay Shubrook (PI, Clinical Trial) Takeda A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Alogliptin Compared with Placebo in Pediatric Subjects with Type 2 Diabetes Mellitus 12/01/2016 - 12/31/2017  
Stacey Pierce-Talsma AACOM Pilot Implementation of an Osteopathic Principles and Practices Survey and Faculty Development Program to Increase the Use of Osteopathic Principles and Practices in Core Clinical Clerkships 07/01/2016 - 12/31/2017 $10,000
Tony Vu AAPA SRFC Expansion Project 08/01/2016 - 06/30/2017 $1000
Miriam Gochin NIH, 1R21AI122847 Mechanism of indole compounds as HIV fusion inhibitors 02/01/2016 - 1/31/2018 $393,250
Jay Shubrook (PI, Clinical Trial) Astra Zeneca A Multi-Center, Randomised, Double-Blind, Active-Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin 5mg Co-administered with Dapagliflozin 5mg compared to Saxagliptin 5mg or Dapagliflozin 5mg all given as Add-on therapy to Metformin in Patients with Type 2 Diabetes who have Inadequate Glycemic Control on Metformin Alone 12/01/2016 - 12/31/2017  
Jay Shubrook (PI, Clinical Trial) Lilly A Randomized, Double-Blind Study with an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide with Placebo in Pediatric Patients with Type 2 Diabetes Mellitus 01/01/2017 - 12/31/2019  

Walter Hartwig (PI)
Richard Reimer (Co-I)
Glenn Davis (Co-I)

AOA & A.T. Still Foundation Patient Experience of Osteopathic Physician Distinction and Empathy 09/01/2016 - 02/28/2018 $100,000

Andrea Taylor (PI)

National Science Foundation Function & Evolution of Jaw-Muscle Fiber Type in Primates 12/01/2016 - 03/31/2017 $224,278

Andrea Taylor (PI)

National Science Foundation Collaborative Research: Integrative Investigation of the Evolution and Biomechanics of Mandibular Form in Hominids, 12/01/2016 - 06/30/2018 $72,542


Grace Landel (PI) OSHPD, 13-4214 Song Brown Physician Assistant Program 06/30/2014 - 06/29/2017 $149,688
Grace Landel (PI) HRSA, T08HP30171 Scholarships for Disadvantaged Students 07/01/2016 - 06/30/2020 $2,520,000
Grace Landel (PI) OSHPD, 15-6594 Song Brown Physician Assistant Program 07/01/2016 - 06/30/2017 $185,000
Ann Stoltz (PI) Frank M. & Gertrude R. Doyle Foundation Interprofessional Simulation Center 11/01/2016 - 06/30/2017 $103,575

Justin Heard (PI) 

VCUSD The Vallejo Careers Pathway Trust Grant Initiative 07/01/2015 - 06/30/2017 $200,000


Alison McCormick (PI) NIH, R21AI121749 Virus-DNA-Virus hybrid vaccines for the prevention of Influenza 01/01/2017 - 12/31/2018 $413,125
Alison McCormick
(PI, subcontract)
NIH, R21AI122108 Preclinical Development of a Multivalent Tularemia Vaccine 06/01/2016 - 05/31/2018 $200,200
Alison McCormick
(PI, subcontract)
NYMC Seed Funding A Novel Approach of Tageted Immunotherapy in Combination with an EBV Vaccine Against EBV Positive B Cell Lymphoma 07/01/2016 - 06/30/2017 $17,767
Shankar Chinta American Parkinson Disease Association Pharmacological activation of TFEB ysing a small molecule promotes autophagic clearance of aggregated a-synuclein: Implications for Parkinson's disease. 09/01/2016 - 08/31/2017 $50,000